Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

Autor: Stefanie, Schulz, Gert, Richardt, Karl-Ludwig, Laugwitz, Tanja, Morath, Julia, Neudecker, Petra, Hoppmann, Roxana, Mehran, Anthony H, Gershlick, Ralph, Tölg, K, Anette Fiedler, Mohamed, Abdel-Wahab, Sebastian, Kufner, Simon, Schneider, Heribert, Schunkert, Tareq, Ibrahim, Julinda, Mehilli, Adnan, Kastrati

Publikováno v: European Heart Journal. 35:2285-2294

Aims Whether prasugrel plus bivalirudin is a superior strategy to unfractionated heparin plus clopidogrel in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) has never been a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcca1ea42207f02cf53ec10c23dd13c0
https://doi.org/10.1093/eurheartj/ehu182

Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study

Autor: Stefanie Schulz, Karl-Ludwig Laugwitz, Adnan Kastrati, Nikolaus Sarafoff, Michael Maeng, Tareq Ibrahim, Robert A. Byrne, K. Anette Fiedler, Julinda Mehilli, Dirk Sibbing

Publikováno v: Fiedler, K A, Byrne, R A, Schulz, S, Sibbing, D, Mehilli, J, Ibrahim, T, Maeng, M, Laugwitz, K-L, Kastrati, A & Sarafoff, N 2014, ' Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study ', American Heart Journal, vol. 167, no. 4, pp. 459-465.e1 . https://doi.org/10.1016/j.ahj.2014.01.005

BACKGROUND: An increasing number of patients undergoing coronary stenting need lifelong anticoagulation and therefore require a triple therapy typically consisting of aspirin, clopidogrel, and a vitamin K antagonist. Triple therapy confers an elevate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71d38816d7a71804b46f0116fe44bea3
https://pubmed.ncbi.nlm.nih.gov/24655693

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction.

Autor: Schulz S; Deutsches Herzzentrum München, Technische Universität, Munich, Germany DZHK, Partner Site Munich Heart Alliance, Munich, Germany schulzs@dhm.mhn.de., Richardt G; Herzzentrum Segeberger Kliniken GmbH, Bad Segeberg, Germany., Laugwitz KL; DZHK, Partner Site Munich Heart Alliance, Munich, Germany 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Morath T; Deutsches Herzzentrum München, Technische Universität, Munich, Germany., Neudecker J; Deutsches Herzzentrum München, Technische Universität, Munich, Germany., Hoppmann P; 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Mehran R; Mount Sinai School of Medicine, New York, USA., Gershlick AH; Department of Cardiovascular Sciences, University of Leicester and NIHR Biomedical Research Unit in Cardiovascular Disease and University Hospitals of Leicester, Leicester, UK., Tölg R; Herzzentrum Segeberger Kliniken GmbH, Bad Segeberg, Germany., Anette Fiedler K; Deutsches Herzzentrum München, Technische Universität, Munich, Germany., Abdel-Wahab M; Herzzentrum Segeberger Kliniken GmbH, Bad Segeberg, Germany., Kufner S; Deutsches Herzzentrum München, Technische Universität, Munich, Germany., Schneider S; 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Schunkert H; Deutsches Herzzentrum München, Technische Universität, Munich, Germany DZHK, Partner Site Munich Heart Alliance, Munich, Germany., Ibrahim T; 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Mehilli J; DZHK, Partner Site Munich Heart Alliance, Munich, Germany Medizinische Klinik und Poliklinik I, Klinikum der LMU, Munich, Germany., Kastrati A; Deutsches Herzzentrum München, Technische Universität, Munich, Germany DZHK, Partner Site Munich Heart Alliance, Munich, Germany.

Publikováno v: European heart journal [Eur Heart J] 2014 Sep 07; Vol. 35 (34), pp. 2285-94. Date of Electronic Publication: 2014 May 09.